Research Article
Open access
Published on 15 May 2025
Download pdf
Wang,C. (2025). Diagnosis and Treatment of Feline Infectious Peritonitis. Theoretical and Natural Science,110,99-104.
Export citation

Diagnosis and Treatment of Feline Infectious Peritonitis

Chenfei Wang *,1,
  • 1 Beijing Haidian Foreign Language Shiyan School, Xingshikou Road, Beijing, China

* Author to whom correspondence should be addressed.

https://doi.org/10.54254/2753-8818/2025.AU22989

Abstract

Feline infectious peritonitis (FIP), caused by feline coronavirus (FCoV), remains a devastating disease with high mortality and no universally effective treatment. This research was undertaken to understand FIP pathogenesis and to evaluate emerging solutions, particularly focusing on innovative vaccine designs and antiviral treatments. The growing evidence of successful clinical interventions highlights both the progress made and the critical gaps remaining in FIP management. This research systematically examines FIP's complex pathogenesis, involving viral mutations (particularly in the spike protein) and immune dysregulation mechanisms. It explores four major vaccine approaches, including multi-epitope vaccines targeting immunodominant regions, live-attenuated vaccines with gene deletions, mutation-based spike protein vaccines, and VNAR antibody therapies. For treatment, this research analyzes three key strategies, including antiviral drugs (GS-441524 and GC376), lysosomal pH modulators (CQ/HCQ), and supportive care protocols. Each section presents experimental evidence while noting limitations such as variable efficacy, safety concerns, and the need for further validation. Special attention is given to comparative effectiveness between different treatment modalities and the challenges of clinical translation. This comprehensive analysis provides valuable insights for researchers developing next-generation FIP interventions. The identified promising directions, particularly combination therapies and structure-based vaccine design, may inform future human coronavirus research. Ultimately, this work contributes to the global effort to transform FIP from a fatal diagnosis to a manageable condition, with implications extending beyond feline medicine to broader virology and immunology fields.

Keywords

Feline infectious peritonitis, Feline coronavirus, Vaccine design, Antiviral therapy, Immune response

[1]. Pedersen, N. C., Eckstrand, C., Liu, H., Leutenegger, C., & Murphy, B. (2015). Levels of feline infectious peritonitis virus in blood, effusions, and various tissues and the role of lymphopenia in disease outcome following experimental infection. Veterinary microbiology, 175(2-4), 157-166.

[2]. Katayama, M., Uemura, Y., & Katori, D. (2024). Effect of Nucleic Acid Analog Administration on Fluctuations in the Albumin-to-Globulin Ratio in Cats with Feline Infectious Peritonitis. Animals, 14(9), 1322.

[3]. Tasker, S., Addie, D. D., Egberink, H., Hofmann-Lehmann, R., Hosie, M. J., Truyen, U., ... & Hartmann, K. (2023). Feline infectious peritonitis: European advisory board on cat diseases guidelines. Viruses, 15(9), 1847.

[4]. Chawla, M., Cuspoca, A. F., Akthar, N., Magdaleno, J. S., Rattanabunyong, S., Suwattanasophon, C., Jongkon, N., Choowongkomon, K., Shaikh, A. R., Malik, T., & Cavallo, L. (2023). Immunoinformatics-aided rational design of a multi-epitope vaccine targeting feline infectious peritonitis virus. Frontiers in Veterinary Science, 10, 1280273.

[5]. Haijema, B. J., Volders, H., & Rottier, P. J. (2004). Live, attenuated coronavirus vaccines through the directed deletion of group-specific genes provide protection against feline infectious peritonitis. Journal of virology, 78(8), 3863-3871.

[6]. Lutz, M., Steiner, A. R., Cattori, V., Hofmann-Lehmann, R., Lutz, H., Kipar, A., & Meli, M. L. (2020). FCoV Viral Sequences of Systemically Infected Healthy Cats Lack Gene Mutations Previously Linked to the Development of FIP. Pathogens, 9(8), 603.

[7]. Tsai, C.-H., Wang, K.-T., Guo, X., & Wu, T.-M. (2023). Yeast Surface Dual Display Platform for Rapid Discovery of Shark VNAR from a Semi-Synthetic Library Followed by Next-Generation Sequencing. Applied Sciences, 13(20), 11520.

[8]. Delaplace, M., Huet, H., Gambino, A., & Le Poder, S. (2021). Feline coronavirus antivirals: a review. Pathogens, 10(9), 1150.

[9]. Aleksić-Kovačević, S., & Marinković, D. (2004). Feline infectious peritonitis (FIP) in our section material. Veterinarski glasnik, 58(1-2), 121-126.

Cite this article

Wang,C. (2025). Diagnosis and Treatment of Feline Infectious Peritonitis. Theoretical and Natural Science,110,99-104.

Data availability

The datasets used and/or analyzed during the current study will be available from the authors upon reasonable request.

Disclaimer/Publisher's Note

The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of EWA Publishing and/or the editor(s). EWA Publishing and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

About volume

Volume title: Proceedings of ICEGEE 2025 Symposium: Sensor Technology and Multimodal Data Analysis

ISBN:978-1-80590-107-5(Print) / 978-1-80590-108-2(Online)
Conference date: 16 June 2025
Editor:Alan Wang
Series: Theoretical and Natural Science
Volume number: Vol.110
ISSN:2753-8818(Print) / 2753-8826(Online)

© 2024 by the author(s). Licensee EWA Publishing, Oxford, UK. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license. Authors who publish this series agree to the following terms:
1. Authors retain copyright and grant the series right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this series.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the series's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this series.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See Open access policy for details).